Insider · CIK 0001526064

Parker Craig C

Reports to the SEC for 4 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001526064

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-15	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+1,622 sh	$8.11	+$13.2K	18,175
2026-05-04	SRZNSurrozen, Inc./DES Sale	Director, Chief Executive Officer	SSale	−4,524 sh	$33.33	−$151K	16,553
2026-05-01	SRZNSurrozen, Inc./DEM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+12.5K sh	—	—	21,077
2026-05-01	SRZNSurrozen, Inc./DE · Restricted Stock UnitM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−12.5K sh	—	—	12,500
2026-02-17	SRZNSurrozen, Inc./DE · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+242K sh	—	—	242,200
2026-02-17	SRZNSurrozen, Inc./DE · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+242K sh	—	—	242,200
2025-12-15	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+1,553 sh	$8.11	+$12.6K	8,577
2025-06-13	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+400 sh	$8.06	+$3,224	7,024
2025-05-01	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+75K sh	—	—	75,000
2025-05-01	SRZNSurrozen, Inc./DE · Restricted Stock UnitA Award	Director, Chief Executive Officer	AAward	+25K sh	—	—	25,000
2025-03-24	SRZNSurrozen, Inc./DE · Series A Common Stock Warrant (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1,474 sh	—	—	0
2025-03-24	SRZNSurrozen, Inc./DE · Series B Common Stock Warrant (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−1,603 sh	—	—	0
2025-03-24	SRZNSurrozen, Inc./DE · Series C Common Stock Warrant (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−5,712 sh	—	—	0
2025-03-24	SRZNSurrozen, Inc./DE · Series D Common Stock Warrant (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−5,712 sh	—	—	0
2025-03-24	SRZNSurrozen, Inc./DE · Series A Common Stock Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+1,474 sh	—	—	1,474
2025-03-24	SRZNSurrozen, Inc./DE · Series B Common Stock Warrant (right to buy)A Award	Director, Chief Executive Officer	AAward	+1,603 sh	—	—	1,603
2025-01-17	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2024-06-14	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+400 sh	$5.67	+$2,268	5,824
2024-05-01	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+43K sh	—	—	43,000
2024-04-24	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+43K sh	—	—	43,000
2024-04-04	SRZNSurrozen, Inc./DEP Purchase	Director, Chief Executive Officer	PPurchase	+1,474 sh	—	—	1,474
2024-04-04	SRZNSurrozen, Inc./DE · Series A Common Stock Warrant (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+1,474 sh	—	—	1,474
2024-04-04	SRZNSurrozen, Inc./DE · Series B Common Stock Warrant (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+1,603 sh	—	—	1,603
2024-04-04	SRZNSurrozen, Inc./DE · Series C Common Stock Warrant (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+5,712 sh	—	—	5,712
2024-04-04	SRZNSurrozen, Inc./DE · Series D Common Stock Warrant (right to buy)P Purchase	Director, Chief Executive Officer	PPurchase	+5,712 sh	—	—	5,712
2024-01-29	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+33 sh	—	—	33
2023-12-15	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+2,046 sh	$5.67	+$11.6K	2,046
2023-06-15	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+25K sh	$0.38	+$9,500	34,578
2023-03-01	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+405K sh	—	—	405,000
2022-12-15	SRZNSurrozen, Inc./DEA Award	Director, Chief Executive Officer	AAward	+9,578 sh	$0.41	+$3,926.98	9,578
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−36K sh	—	—	0
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2,065 sh	—	—	0
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−181K sh	—	—	0
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−315K sh	—	—	0
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+36K sh	—	—	35,987
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+315K sh	—	—	315,310
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+181K sh	—	—	181,270
2022-10-10	SRZNSurrozen, Inc./DE · Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+2,065 sh	—	—	2,065
2022-03-01	SRZNSurrozen, Inc./DE · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+370K sh	—	—	370,000
2021-08-12	SRZNSurrozen, Inc./DE · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+183K sh	—	—	183,335
2018-04-30	VTVTvTv Therapeutics Inc. · Director stock option (right to buy)A Award	Director	AAward	+15K sh	$1.79	+$26.9K	70,000
2017-05-01	VTVTvTv Therapeutics Inc. · Director stock option (right to buy)A Award	Director	AAward	+15K sh	$5.31	+$79.7K	55,000
2016-05-12	VTVTvTv Therapeutics Inc. · Director stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	40,000
2015-08-04	VTVTvTv Therapeutics Inc. · Director stock option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2014-02-10	GERNGERON CORP · Employee Stock Option (right to buy)A Award	EVP, Corp Dev & Sci Affairs	AAward	+400K sh	—	—	400,000
2013-02-12	GERNGERON CORP · Employee Stock Option (right to buy)A Award	EVP, Corp Dev & Sci Affairs	AAward	+400K sh	—	—	400,000
2012-07-30	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyD Disposition to Issuer	Sr VP Strategy and Corporate D	DDisposition to Issuer	−54K sh	$14.25	−$770K	0
2012-03-10	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyA Award	Sr VP Strategy and Corporate D	AAward	+54K sh	—	—	54,000
2011-08-08	HUMAN GENOME SCIENCES INCEmployee Stock Option - Right to BuyA Award	Sr VP Strategy and Corporate D	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Jun 164
Parker Craig C0001193125-26-272754
SEC(opens sec.gov)
May 54
Parker Craig C0001193125-26-206658
SEC(opens sec.gov)
Feb 184
Parker Craig C0001193125-26-057652
SEC(opens sec.gov)
Dec 164
Parker Craig C0001193125-25-321305
SEC(opens sec.gov)
Jun 164
Parker Craig C0001593968-25-000785
SEC(opens sec.gov)
May 54
Parker Craig C0001593968-25-000591
SEC(opens sec.gov)
Mar 254
Parker Craig C0001593968-25-000413
SEC(opens sec.gov)
Jan 224
Parker Craig C0001593968-25-000112
SEC(opens sec.gov)
Jun 184
Parker Craig C0001593968-24-000867
SEC(opens sec.gov)
May 24
Parker Craig C0001593968-24-000678
SEC(opens sec.gov)
Apr 264
Parker Craig C0001593968-24-000621
SEC(opens sec.gov)

Companies

Address

C/O SURROZEN, INC. 171 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080